(NYSE: LLY) Eli Lilly & Co's forecast annual revenue growth rate of 19.83% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 7.24%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Eli Lilly & Co's revenue in 2025 is $49,003,200,000.On average, 7 Wall Street analysts forecast LLY's revenue for 2025 to be $56,765,615,304,929, with the lowest LLY revenue forecast at $55,508,877,079,070, and the highest LLY revenue forecast at $59,037,104,517,406. On average, 7 Wall Street analysts forecast LLY's revenue for 2026 to be $68,634,108,862,402, with the lowest LLY revenue forecast at $64,623,250,834,737, and the highest LLY revenue forecast at $74,962,619,358,368.
In 2027, LLY is forecast to generate $79,781,413,498,890 in revenue, with the lowest revenue forecast at $74,054,168,297,838 and the highest revenue forecast at $87,697,835,175,658.